Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-03

Clinical Trial Update: As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period [Phase 3]

View source ↗

Summary

Phase 3 trial update on as-needed budesonide/formoterol Turbuhaler for stepping down in asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • budesonide/formoterol Turbuhaler (budesonide/formoterol)

Snippet

Sponsor: Hat Yai Medical Education Center | Conditions: Asthma | Phase 3 | Status: COMPLETED